Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis.

导出 OA

翻译打印收藏纠错

第一作者： Wenjing,Luo

第一单位： Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.

作者： Wenjing,Luo ^[1] ; Chenggong,Li ^[2] ; Yinqiang,Zhang ^[1] ; Mengyi,Du ^[2] ; Haiming,Kou ^[1] ; Cong,Lu ^[2] ; Heng,Mei ^[1] ; Yu,Hu ^[2]

作者单位： Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China. ^[1] Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, 430022, Wuhan, China. ^[2] Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China. hmei@hust.edu.cn. ^[3] Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, 430022, Wuhan, China. hmei@hust.edu.cn. ^[4] Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China. dr_huyu@126.com. ^[5] Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, 430022, Wuhan, China. dr_huyu@126.com. ^[6]

关键词 Chimeric antigen receptor Hematologic toxicity Hematological malignancies Meta-analysis Review